Although it remains uncertain which PDE4 isoform is most effective on CNS disorders, the current evidence supports the fact that PDE4D is an essential mediator of rolipram’s antidepressant-like effects and that PDE4D-regulated signaling may play a key role in the neuroinflammation of MDD and ADRD [94]. The gene discussed is PDE4A; the disease is central nervous system disorder.